BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kukhanova MK, Karpenko IL, Ivanov AV. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs. Molecules 2020;25:E1015. [PMID: 32102413 DOI: 10.3390/molecules25041015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Vesuna F, Akhrymuk I, Smith A, Winnard PT, Lin S, Panny L, Scharpf R, Kehn-hall K, Raman V. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2. Front Microbiol 2022;13:959577. [DOI: 10.3389/fmicb.2022.959577] [Reference Citation Analysis]
2 Kwon J, Choi H, Han C. A Dual Role of DDX3X in dsRNA-Derived Innate Immune Signaling. Front Mol Biosci 2022;9:912727. [PMID: 35874614 DOI: 10.3389/fmolb.2022.912727] [Reference Citation Analysis]
3 Zhao JZ, Xu LM, Ren GM, Shao YZ, Lu TY. Identification and characterization of DEAD-box RNA helicase DDX3 in rainbow trout (Oncorhynchus mykiss) and its relationship with infectious hematopoietic necrosis virus infection. Dev Comp Immunol 2022;135:104493. [PMID: 35840014 DOI: 10.1016/j.dci.2022.104493] [Reference Citation Analysis]
4 Rampogu S, Lemuel MR, Lee KW. Virtual screening, molecular docking, molecular dynamics simulations and free energy calculations to discover potential DDX3 inhibitors. Advances in Cancer Biology - Metastasis 2022;4:100022. [DOI: 10.1016/j.adcanc.2021.100022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dong M, Wen X, He X, Ren J, Yu H, Qin Y, Yang Z, Yang M, Zhou C, Zhang H, Cheng S, Chen J. HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis. Front Immunol 2022;13:871558. [DOI: 10.3389/fimmu.2022.871558] [Reference Citation Analysis]
6 Rao S, Mahmoudi T. DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism. Front Cell Dev Biol 2022;10:917599. [DOI: 10.3389/fcell.2022.917599] [Reference Citation Analysis]
7 Castelli LM, Benson BC, Huang WP, Lin YH, Hautbergue GM. RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration. Front Genet 2022;13:886563. [PMID: 35646086 DOI: 10.3389/fgene.2022.886563] [Reference Citation Analysis]
8 Hu M, Zheng H, Wu J, Sun Y, Wang T, Chen S. DDX5: an expectable treater for viral infection- a literature review. Ann Transl Med 2022;10:712. [PMID: 35845539 DOI: 10.21037/atm-22-2375] [Reference Citation Analysis]
9 Vandelli A, Vocino G, Tartaglia GG. Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis. Front Mol Biosci 2022;9:893067. [DOI: 10.3389/fmolb.2022.893067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tabassum S, Ghosh MK. DEAD-box RNA helicases with special reference to p68: Unwinding their biology, versatility, and therapeutic opportunity in cancer. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.02.008] [Reference Citation Analysis]
11 Zhang H, He C, Guo X, Fang Y, Lai Q, Wang X, Pan X, Li H, Qin K, Li A, Liu S, Li Q. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00827-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Governa P, Manetti F. Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view. Eur J Med Chem 2021;229:114078. [PMID: 34992041 DOI: 10.1016/j.ejmech.2021.114078] [Reference Citation Analysis]
13 Marecki JC, Belachew B, Gao J, Raney KD. RNA helicases required for viral propagation in humans. Enzymes 2021;50:335-67. [PMID: 34861942 DOI: 10.1016/bs.enz.2021.09.005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Shikalov AB, Sergeeva OV, Zatsepin TS. Determination of the Affinity of Eukaryotic DDX3 RNA Helicase to the Characteristic Elements of mRNA Secondary Structure. Dokl Biochem Biophys 2021;500:297-9. [PMID: 34697730 DOI: 10.1134/S1607672921050173] [Reference Citation Analysis]
15 Gherardini L, Inzalaco G, Imperatore F, D'Aurizio R, Franci L, Miragliotta V, Boccuto A, Calandro P, Andreini M, Tarditi A, Chiariello M. The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models. Cancers (Basel) 2021;13:4830. [PMID: 34638314 DOI: 10.3390/cancers13194830] [Reference Citation Analysis]
16 Rampogu S, Kim SM, Shaik B, Lee G, Kim JH, Kim GS, Lee KW, Kim MO. Novel Butein Derivatives Repress DDX3 Expression by Inhibiting PI3K/AKT Signaling Pathway in MCF-7 and MDA-MB-231 Cell Lines. Front Oncol 2021;11:712824. [PMID: 34485148 DOI: 10.3389/fonc.2021.712824] [Reference Citation Analysis]
17 de Castro Fonseca M, de Oliveira JF, Araujo BHS, Canateli C, do Prado PFV, Amorim Neto DP, Bosque BP, Rodrigues PV, de Godoy JVP, Tostes K, Filho HVR, Nascimento AFZ, Saito A, Tonoli CCC, Batista FAH, de Oliveira PSL, Figueira AC, Souza da Costa S, Krepischi ACV, Rosenberg C, Westfahl H Jr, da Silva AJR, Franchini KG. Molecular and cellular basis of hyperassembly and protein aggregation driven by a rare pathogenic mutation in DDX3X. iScience 2021;24:102841. [PMID: 34381968 DOI: 10.1016/j.isci.2021.102841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Hernández-Díaz T, Valiente-Echeverría F, Soto-Rifo R. RNA Helicase DDX3: A Double-Edged Sword for Viral Replication and Immune Signaling. Microorganisms 2021;9:1206. [PMID: 34204859 DOI: 10.3390/microorganisms9061206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
19 He X, Li T, Qin K, Luo S, Li Z, Ji Q, Song H, He H, Tang H, Han C, Li H, Luo Y. Demalonylation of DDX3 by Sirtuin 5 promotes antiviral innate immune responses. Theranostics 2021;11:7235-46. [PMID: 34158847 DOI: 10.7150/thno.52934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Moore AFT, de Victoria AL, Koculi E. Interactions of the C-Terminal Truncated DEAD-Box Protein DDX3X With RNA and Nucleotide Substrates. ACS Omega 2021;6:12640-6. [PMID: 34056415 DOI: 10.1021/acsomega.1c00700] [Reference Citation Analysis]
21 Rao S, Lungu C, Crespo R, Steijaert TH, Gorska A, Palstra RJ, Prins HAB, van Ijcken W, Mueller YM, van Kampen JJA, Verbon A, Katsikis PD, Boucher CAB, Rokx C, Gruters RA, Mahmoudi T. Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir. Nat Commun 2021;12:2475. [PMID: 33931637 DOI: 10.1038/s41467-021-22608-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
22 Ciccosanti F, Di Rienzo M, Romagnoli A, Colavita F, Refolo G, Castilletti C, Agrati C, Brai A, Manetti F, Botta L, Capobianchi MR, Ippolito G, Piacentini M, Fimia GM. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res 2021;190:105064. [PMID: 33781803 DOI: 10.1016/j.antiviral.2021.105064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sergeeva O, Zatsepin T. RNA Helicases as Shadow Modulators of Cell Cycle Progression. Int J Mol Sci 2021;22:2984. [PMID: 33804185 DOI: 10.3390/ijms22062984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Taroncher-Oldenburg G, Müller C, Obermann W, Ziebuhr J, Hartmann RK, Grünweller A. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics. Microorganisms 2021;9:540. [PMID: 33807988 DOI: 10.3390/microorganisms9030540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Malki Y, Martinez J, Masurier N. 1,3-Diazepine: A privileged scaffold in medicinal chemistry. Med Res Rev 2021;41:2247-315. [PMID: 33645848 DOI: 10.1002/med.21795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ali MAM. DEAD-box RNA helicases: The driving forces behind RNA metabolism at the crossroad of viral replication and antiviral innate immunity. Virus Res 2021;296:198352. [PMID: 33640359 DOI: 10.1016/j.virusres.2021.198352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mo J, Liang H, Su C, Li P, Chen J, Zhang B. DDX3X: structure, physiologic functions and cancer. Mol Cancer 2021;20:38. [PMID: 33627125 DOI: 10.1186/s12943-021-01325-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
28 Mokdadi M, Abdelkrim YZ, Banroques J, Huvelle E, Oualha R, Yeter-Alat H, Guizani I, Barhoumi M, Tanner NK. The In Silico Identification of Potential Members of the Ded1/DDX3 Subfamily of DEAD-Box RNA Helicases from the Protozoan Parasite Leishmania infantum and Their Analyses in Yeast. Genes (Basel) 2021;12:212. [PMID: 33535521 DOI: 10.3390/genes12020212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Francies FZ, Dlamini Z. Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies. Cells 2021;10:239. [PMID: 33530521 DOI: 10.3390/cells10020239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chen L, Xu M, Zhong W, Hu Y, Wang G. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway. Exp Cell Res 2021;399:112448. [PMID: 33347858 DOI: 10.1016/j.yexcr.2020.112448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Winnard PT Jr, Vesuna F, Raman V. Targeting host DEAD-box RNA helicase DDX3X for treating viral infections. Antiviral Res 2021;185:104994. [PMID: 33301755 DOI: 10.1016/j.antiviral.2020.104994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
32 Weiße J, Rosemann J, Krauspe V, Kappler M, Eckert AW, Haemmerle M, Gutschner T. RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6835. [PMID: 32957697 DOI: 10.3390/ijms21186835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
33 Rampogu S, Kim SM, Son M, Baek A, Park C, Lee G, Kim Y, Kim GS, Kim JH, Lee KW. A Computational Approach with Biological Evaluation: Combinatorial Treatment of Curcumin and Exemestane Synergistically Regulates DDX3 Expression in Cancer Cell Lines. Biomolecules 2020;10:E857. [PMID: 32512851 DOI: 10.3390/biom10060857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]